 |
 |
March 2013MesoRFA Newsletter: Winter 2012 Edition Message from Executive Director, Birdslanding event review, Annual golf invitational review, Roger Hamilton Memorial review, John S. Lyons Memorial review, S. California Pipetrades event review, and more. October 29, 2012PhRMA Golf Invitational MesoRFA is blessed with 6th final event of 2012 fundraising efforts. The Pharmaceutical Research and Manufacturers of America and the California State Building and Construction Trades make MesoRFA the benefactor of nearly $11,000, 100% of which will go towards mesothelioma research! October 22, 2012District Council 16 Aim to Cure The Southern California Pipetrades District Council 16 organizes a fantastic event to help find a cure for mesothelioma. The Aim to Cure event was an overwhelming success generating approximately $52,000 for mesothelioma research! September 8, 2012John S. Lyons Memorial Banquet of 2012 This year marked a milestone for the JOHNS who celebrated today’s Labor Leader of the Year at their 30th Annual Memorial Banquet. Since its inception the JOHNS have donated nearly $1,300,000.00 to local charities! The Mesothelioma Research Foundation of America is honored to be chosen as one of the benefactors of this year’s event and in years past. Bring your questions to Dr. Gill: click HERE DONATIONS for cancer cure 100 percent of all proceeds received are going to the USC Norris Comprehensive Cancer Medical Center in Los Angeles to support the FDA Phase III of Dr. Gill's clinical trials. These trials are for Veglin, a mesothelioma cancer treatment. Veglin manipulates the blood vessels to starve a malignant tumor while alleviating fluid build up in the lungs Support the hope in this research and click HERE Patient Assistance Programs are offered by many pharmaceutical manufacturers to help pay for medications. These offers are sometimes called Indigent Drug Programs. Use our link just following, and learn whether a specific drug might be available at reduced cost or for free. Drug Assistance Programs: click HERE At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of the pharmaceutical company that makes the drug you are using Find the lastest Mesothelioma clinical trials: click HERE To ask Dr. Gill a question: click HERE Help this Foundation and click HERE March 14, 2012News Release The entire staff at the Mesothelioma Research Foundation of America stops and takes a deliberate moment to recognize and send a sincere thanks to the JOHNS for their donation of $5,000 designated for mesothelioma cancer research. The JOHNS event is held annually to honor a dear deceased friend, John S. Lyons, by acknowledging today's Labor Leader of the Year as well as raise money for cancer research and other local charities.
Financial help for cancer patients: click HERE At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of organizations that provide financial assistance. Bring your questions to Dr. Gill: click HERE Help grow the Foundation and cancer-cure research: click HERE |
Cancer imposes heavy economic burdens on a cancer patients and family members alike. Resources are available for individuals who do not have health insurance or who need financial assistance to cover health care costs. Our listing will help you find Government agencies, private organizations, and programs that are designed to provide assistance for a cancer patient and their family. 
Clinical Trials Status
October 1, 2012
Dr. Parkash Gill
Dr. Parkash Gill of the USC Norris Comprehensive Cancer Center has announced that the new cancer fighting drug EPH-B4 has been submitted to the FDA for Phase I Clinical Trials and is available to qualifying mesothelioma patients. In the initial Phase I Trial EPH-B4 is available to newly diagnosed patients who have not undergone any conventional treatment options and to those patients who have exhausted all other treatment options such as surgery and chemotherapy. This is truly exciting as Dr. Gill has reported that EPH-B4 has shown great promise as a solo treatment or in conjunction with other drugs as Alimta, Cisplatin and Carboplatin.
Please use our FaceBook link 
to obtain your FREE copy of our eBook that teaches:
10 Easy Steps On How To Find And Choose A Clinical Trial For Mesothelioma And How To Prepare For It!
Ask Dr. Gill about your specific mesothelioma issues here: Ask Dr. Gill
In addition to the eBook found at our Facebook fan page, also learn more about clinical trials from these links:
Lyons Foundation Chooses MesoRFA
The Mesothelioma Research Foundation of America is the proud recipient of a grant from the John S. Lyons Memorial Foundation, charitable branch of the San Diego Building Trades Councel, to help support clinical studies of Dr. Parkash Gill's protein known as EPH B4 as a mesothelioma cancer treatment option.
 |
 |
THE FOUNDATION
The Mesothelioma Research Foundation of America has a mission: fund research that will lead to the quickest cure for mesothelioma. Mesothelioma is a cancer of the lining of the lungs caused by asbestos exposure. This cancer disease had few treatment options until this Foundation and Dr. Parkash Gill's work created better treatment options. Today, the future looks more hopeful for additional improved treatment options available to those stricken by this cancer.
The Foundation Board Members from the left are: James W. Kellogg, Jerry Neil Paul, Elizabeth Ann Paul and Dr. Parkash Gill, M.D. These are respectively the United Association International Representative, Founding Director, Executive Director and Chairman of the Medical Advisory Board.
The Mesothelioma Research Foundation of America began funding research for a cure in 2001 with the opening of the Mesothelioma Laboratory at USC Norris Comprehensive Cancer Medical Center in Los Angeles under the supervision of Dr. Parkash Gill.
Dr. Gill is a board certified oncologist and hematologist who has received FDA approval from the U.S. Government to do Clinical Trials on a mesothelioma treatment drug called Veglin. We believe there is great promise and hope in Veglin and the Mesothelioma Research Foundation of America has funded 100% of Dr. Gill's research.
Veglin proved successful in Phase I and Phase II clinical trials. Many are very hopeful for the possibilities of a more effective cancer treatment compared to what presently is available for mesothelioma victims. We are currently waiting for further FDA approval to begin Veglin as soon as possible.
For questions related to the foundation and to make contributions please contact:
Executive Director
Toll Free:
(800) 909-Meso (6376)
5716 Corsa Avenue, Suite 203
Westlake Village, CA 91362
For more information and other questions contact:
(800) 909-6376
©2012 Mesothelioma Research Foundation Of America